Skip to main content

Table 2 Characteristics of the survivors and non-survivors and the univariable Cox proportional hazards model for 28-day mortality in the development set

From: Development and validation of the VitaL CLASS score to predict mortality in stage IV solid cancer patients with septic shock in the emergency department: a multi-center, prospective cohort study

Characteristics

Comparison

Univariable analysis

Survivors (n = 349)

Non-survivors (n = 120)

HR

95% CI

p value

Age, years

66.0 (60.0–74.0)

69.0 (60.0–75.0)

1.018

1.000–1.036

0.05

Sex

 Male

210 (60.2)

82 (68.3)

1.000

 

 Female

139 (39.8)

38 (31.7)

0.739

0.503–1.086

0.12

Hypertension

 No

250 (71.6)

76 (63.3)

1.000

 

 Yes

99 (28.4)

44 (36.7)

1.382

0.954–2.004

0.09

Diabetes mellitus

 No

260 (74.5)

87 (72.5)

1.000

 

 Yes

89 (25.4)

33 (27.7)

1.144

0.766–1.707

0.51

Cancer type

 Lung

40 (11.5)

39 (32.5)

1.000

 

 Hepatobiliary-pancreas

122 (35.0)

29 (24.2)

0.329

0.203–0.533

< 0.001

 Gastrointestinal

50 (14.3)

12 (10.0)

0.325

0.170–0.622

0.001

 Gynecologic

44 (12.6)

5 (4.2)

0.164

0.065–0.416

< 0.001

 Urologic

33 (9.5)

9 (7.5)

0.362

0.175–0.748

0.006

 Others

60 (17.2)

26 (21.7)

0.548

0.334–0.901

0.02

Focus of infection

 Pneumonia

61 (17.5)

45 (37.5)

1.000

 

 Urinary tract infection

53 (15.2)

12 (10.0)

0.390

0.206–0.738

0.004

 Colitis

45 (12.9)

14 (11.7)

0.519

0.285–0.945

0.03

 Cholangitis/cholecystitis

106 (30.4)

24 (20.0)

0.387

0.235–0.635

< 0.001

 Others/unknown

63 (18.1)

12 (10.0)

0.329

0.174–0.622

0.001

 Multiple focus

21 (6.0)

13 (10.8)

0.878

0.474–1.627

0.68

Vital signs at ED admission

 Systolic BP, mmHg

90.0 (79.0–110.0)

90.0 (78.0–118.5)

1.004

0.998–1.011

0.20

 Diastolic BP, mmHg

57.0 (48.0–66.0)

56.0 (49.0–70.0)

1.005

0.995–1.014

0.33

 Heart rate/min

115 (97–131)

117 (96–132)

1.001

0.993–1.008

0.84

 Respiratory rate/min

20 (18–22)

22 (20–26)

1.084

1.057–1.113

< 0.001

 Body temperature, °C

38.1 (37.1–39.0)

37.3 (36.6–37.9)

0.638

0.546–0.745

< 0.001

 Altered mentation

36 (50.7)

35 (49.3)

2.988

2.014–4.431

< 0.001

Laboratory values

 White blood cell, /μL

7890 (2740–14,300)

9815 (4365–17,570)

1.000

1.000–1.000

0.04

 Hemoglobin, g/dL

10.2 (8.5–11.6)

9.8 (8.4–11.5)

0.994

0.915–1.080

0.88

 Platelet count, × 1000/μL

144 (70–228)

140 (66–224)

1.000

0.998–1.001

0.69

 PT, INR

1.25 (1.14–1.43)

1.39 (1.25–1.61)

1.229

1.075–1.405

0.003

 Albumin, g/dL

2.9 (2.5–3.3)

2.5 (2.2–3.0)

0.451

0.334–0.610

< 0.001

 BUN, mg/dL

23 (16–33)

30 (19–44)

1.012

1.005–1.018

0.001

 Creatinine, mg/dL

1.16 (0.87–1.80)

1.29 (0.84–2.19)

1.104

0.987–1.233

0.08

 CRP, mg/dL

12.0 (5.8–20.6)

14.0 (7.6–25.4)

1.011

0.997–1.026

0.13

 Lactic acid, mmol/L

3.1 (1.8–4.9)

4.6 (2.5–8.3)

1.177

1.127–1.228

< 0.001

Severity scorea

 SOFA score

7.0 (5.0–9.0)

10.0 (7.0–13.0)

1.246

1.190–1.305

< 0.001

 APACHE II score

18.0 (14.0–23.0)

24.0 (18.0–32.0)

1.088

1.069–1.108

< 0.001

  1. Values are presented as median (interquartile range) or number (percentage), as appropriate
  2. Abbreviations: APACHE Acute Physiology and Chronic Health Evaluation, BP blood pressure, BUN blood urea nitrogen, CI confidence interval, CRP C-reactive protein, ED emergency department, HR hazard ratio, INR international normalized ratio, PT prothrombin time, SOFA Sequential Organ Failure Assessment
  3. aSeverity scores were not included in the multivariate analysis for the final model